Silence Therapeutics plc Cash Flows From Used In Investing Activities
Silence Therapeutics plc (SLN) reported Cash Flows From Used In Investing Activities of GBP 16.43 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2024-03-13
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2023-12-31 | 16.43M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | -16.54M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 8.68M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 9.62M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | -15.02M GBP 20-F · filed 2022-03-17 |
| 2018-12-31 | -4.83M GBP 20-F/A · filed 2021-04-29 |